TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SCINOPHARM TAIWAN

OncologyNeurologyCardiovascular
Generics

SCINOPHARM TAIWAN is a generic drug manufacturer focused on Oncology, Neurology, Cardiovascular. Key products include BORTEZOMIB.

2006
Since
5
Drugs
-
Trials
16
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

GLATIRAMER ACETATE 2026-02-11
GLATIRAMER ACETATE 2026-02-11
BORTEZOMIB 2026-01-06
GLATIRAMER ACETATE 2025-12-31
BORTEZOMIB 2025-12-17
BORTEZOMIB 2025-06-02
GLATIRAMER ACETATE 2025-05-16
Labeling
GLATIRAMER ACETATE 2025-05-16
Labeling
GLATIRAMER ACETATE 2025-05-07
CLOFARABINE 2025-01-03
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 25%
1 drugs
Neurology 25%
1 drugs
Cardiovascular 25%
1 drugs
Respiratory 25%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Novartis big-pharma
Oncology, Cardiovascular, Respiratory
GE HEALTHCARE specialty
Neurology, Cardiovascular, Oncology, Respiratory
GSK big-pharma
Respiratory, Oncology, Neurology
Roche big-pharma
Oncology, Neurology, Respiratory
OTSUKA big-pharma
Neurology, Cardiovascular, Oncology, Respiratory